These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27019077)

  • 1. Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
    Horsfield MA; Rocca MA; Pagani E; Storelli L; Preziosa P; Messina R; Camesasca F; Copetti M; Filippi M
    J Neuroimaging; 2016 Jul; 26(4):395-402. PubMed ID: 27019077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating Nonlinear Registration to Improve Subtraction Images for Lesion Detection and Quantification in Multiple Sclerosis.
    Kotari V; Salha R; Wang D; Wood E; Salvetti M; Ristori G; Tang L; Bagnato F; Ikonomidou VN
    J Neuroimaging; 2018 Jan; 28(1):70-78. PubMed ID: 29064129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian classification of multiple sclerosis lesions in longitudinal MRI using subtraction images.
    Elliott C; Francis SJ; Arnold DL; Collins DL; Arbel T
    Med Image Comput Comput Assist Interv; 2010; 13(Pt 2):290-7. PubMed ID: 20879327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmentation of subtraction images for the measurement of lesion change in multiple sclerosis.
    Duan Y; Hildenbrand PG; Sampat MP; Tate DF; Csapo I; Moraal B; Bakshi R; Barkhof F; Meier DS; Guttmann CR
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):340-6. PubMed ID: 18272569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging.
    Moraal B; Wattjes MP; Geurts JJ; Knol DL; van Schijndel RA; Pouwels PJ; Vrenken H; Barkhof F
    Radiology; 2010 Apr; 255(1):154-63. PubMed ID: 20308453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
    Zhang Y; Gauthier SA; Gupta A; Comunale J; Chia-Yi Chiang G; Zhou D; Chen W; Giambrone AE; Zhu W; Wang Y
    J Magn Reson Imaging; 2016 Aug; 44(2):426-32. PubMed ID: 26800367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.
    Molyneux PD; Tofts PS; Fletcher A; Gunn B; Robinson P; Gallagher H; Moseley IF; Barker GJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):42-7. PubMed ID: 9667559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain MRI lesion load quantification in multiple sclerosis: a comparison between automated multispectral and semi-automated thresholding computer-assisted techniques.
    Achiron A; Gicquel S; Miron S; Faibel M
    Magn Reson Imaging; 2002 Dec; 20(10):713-20. PubMed ID: 12591567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.
    Durand-Dubief F; Belaroussi B; Armspach JP; Dufour M; Roggerone S; Vukusic S; Hannoun S; Sappey-Marinier D; Confavreux C; Cotton F
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1918-24. PubMed ID: 22790248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtraction MR images in a multiple sclerosis multicenter clinical trial setting.
    Moraal B; Meier DS; Poppe PA; Geurts JJ; Vrenken H; Jonker WM; Knol DL; van Schijndel RA; Pouwels PJ; Pohl C; Bauer L; Sandbrink R; Guttmann CR; Barkhof F
    Radiology; 2009 Feb; 250(2):506-14. PubMed ID: 19037018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
    Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
    Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Sclerosis: Improved Detection of Active Cerebral Lesions With 3-Dimensional T1 Black-Blood Magnetic Resonance Imaging Compared With Conventional 3-Dimensional T1 GRE Imaging.
    Sommer NN; Saam T; Coppenrath E; Kooijman H; Kümpfel T; Patzig M; Beyer SE; Sommer WH; Reiser MF; Ertl-Wagner B; Treitl KM
    Invest Radiol; 2018 Jan; 53(1):13-19. PubMed ID: 28858894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
    Pareto D; Sastre-Garriga J; Aymerich FX; Auger C; Tintoré M; Montalban X; Rovira A
    Neuroradiology; 2016 May; 58(5):467-74. PubMed ID: 26847633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
    Wang C; Beadnall HN; Hatton SN; Bader G; Tomic D; Silva DG; Barnett MH
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):754-7. PubMed ID: 27071647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.
    Gonçalves LI; Dos Passos GR; Conzatti LP; Burger JLP; Tomasi GH; Zandoná MÉ; Azambuja LS; Gomes I; Franco A; Sato DK; Becker J
    Mult Scler Relat Disord; 2018 Feb; 20():154-158. PubMed ID: 29414290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of active multiple sclerosis plaques: efficiency of contrast-enhanced magnetization transfer subtraction technique.
    Algin O; Hakyemez B; Taşkapilioğlu O; Parlak M; Turan F
    Diagn Interv Radiol; 2010 Jun; 16(2):106-11. PubMed ID: 20309819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.
    Liguori M; Meier DS; Hildenbrand P; Healy BC; Chitnis T; Baruch NF; Khoury SJ; Weiner HL; Bakshi R; Barkhof F; Guttmann CR
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1125-31. PubMed ID: 21429902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume.
    Connor SE; Gunny R; Hampton T; O'gorman R
    Eur Radiol; 2004 Nov; 14(11):2061-6. PubMed ID: 15252748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis.
    Rovaris M; Inglese M; van Schijndel RA; Sormani MP; Rodegher M; Comi G; Filippi M
    J Neurol; 2000 Dec; 247(12):960-5. PubMed ID: 11200690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.